propranolol has been researched along with amphotericin b in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (27.78) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 12 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jolivette, LJ; Ward, KW | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Azas, N; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Courtioux, B; Fairlamb, A; Hutter, S; Laget, M; Moreau, A; Mothes, E; Paloque, L; Pedron, J; Pratviel, G; Sournia-Saquet, A; Stigliani, JL; Valentin, A; Vendier, L; Verhaeghe, P; Wyllie, S | 1 |
| Candia, OA; Montoreano, R; Podos, SM | 1 |
| Glader, BE; Müller-Soyano, A | 1 |
| Binder, HJ; Dobbins, JW; Racusen, LC; Whiting, DS | 1 |
| Morenz, E; Morenz, J; Schmidt, D | 1 |
| Boucher, RC; Bromberg, PA; Gatzy, JT | 1 |
| Foroumadi, A; Hosseini, NM; Massarrat, S; Pedramnia, S; Saniee, P; Siavoshi, F; Tavakolian, A | 1 |
| Beverley, SM; Corrêa, CM; Madureira, AP; Martins-Filho, OA; Melo, MN; Rocha, MN; Soares, RP | 1 |
| Hauben, M; Hung, EY | 1 |
1 review(s) available for propranolol and amphotericin b
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
17 other study(ies) available for propranolol and amphotericin b
| Article | Year |
|---|---|
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Novel 8-nitroquinolin-2(1H)-ones as NTR-bioactivated antikinetoplastid molecules: Synthesis, electrochemical and SAR study.
Topics: Antiprotozoal Agents; Cell Survival; Dose-Response Relationship, Drug; Electrochemical Techniques; Hep G2 Cells; Humans; Kinetoplastida; Leishmania infantum; Molecular Structure; Nitroquinolines; Nitroreductases; Parasitic Sensitivity Tests; Structure-Activity Relationship; Trypanosoma brucei brucei | 2018 |
Effect of the ionophore A23187 on chloride transport across isolated frog cornea.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Anura; Biological Transport, Active; Calcimycin; Chlorides; Cornea; Dose-Response Relationship, Drug; Epinephrine; Isoproterenol; Magnesium; Membrane Potentials; Phentolamine; Propranolol; Rana catesbeiana | 1977 |
Cation specificity of propranolol-induced changes in RBC membrane permeability: comparative effects in human, dog and cat erythrocytes.
Topics: Amphotericin B; Animals; Calcium; Cats; Cell Membrane Permeability; Dogs; Erythrocyte Membrane; Erythrocytes; Humans; Potassium; Propranolol; Sodium; Species Specificity | 1977 |
Effect of propranolol on ricinoleic acid- and deoxycholic acid-induced changes of intestinal electrolyte movement and mucosal permeability. Evidence against the importance of altered permeability in the production of fluid and electrolyte accumulation.
Topics: Amphotericin B; Animals; Cell Membrane Permeability; Colon; Deoxycholic Acid; Fatty Acids, Unsaturated; Intestinal Mucosa; Inulin; Male; Potassium; Propranolol; Rats; Ricinoleic Acids; Sodium; Urea; Water-Electrolyte Balance | 1978 |
[Effect of drugs on superoxide formation by neutrophilic granulocytes].
Topics: Amphotericin B; Chloramphenicol; Colchicine; Fluphenazine; Humans; Hydrocortisone; Levamisole; Lithium; Lithium Carbonate; Neutrophils; Ouabain; Propranolol; Superoxides | 1987 |
Airway transepithelial electric potential in vivo: species and regional differences.
Topics: Acetylcholine; Amphotericin B; Animals; Atropine; Dogs; Electrophysiology; Epinephrine; Epithelium; Female; Guinea Pigs; Histamine; Isoproterenol; Male; Neurotransmitter Agents; Phentolamine; Phenylephrine; Propranolol; Rabbits; Sotalol; Species Specificity; Trachea | 1980 |
Comparison of the effect of non-antifungal and antifungal agents on Candida isolates from the gastrointestinal tract.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amphotericin B; Antifungal Agents; Antipsychotic Agents; Candida; Candida tropicalis; Colony Count, Microbial; Drug Resistance, Microbial; Gastrointestinal Tract; Humans; Ketoconazole; Lansoprazole; Propranolol; Trifluoperazine | 2012 |
An alternative in vitro drug screening test using Leishmania amazonensis transfected with red fluorescent protein.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Flow Cytometry; Green Fluorescent Proteins; Inhibitory Concentration 50; Leishmania; Luminescent Proteins; Macrophages; Mice; Mice, Inbred BALB C; Organisms, Genetically Modified; Parasitic Sensitivity Tests; Propranolol; Red Fluorescent Protein; Reproducibility of Results; Transfection | 2013 |
A quantitative analysis of the spontaneous reporting of congestive heart failure-related adverse events with systemic anti-fungal drugs.
Topics: Adverse Drug Reaction Reporting Systems; Amphotericin B; Antifungal Agents; Databases, Factual; Drug Interactions; Drug Overdose; Fluconazole; Heart Failure; Humans; Itraconazole; Propranolol | 2013 |